111 related articles for article (PubMed ID: 37633452)
1. Coprescribing of opioids and psychotropic medications among Medicare-enrolled older adults on long-term opioid therapy.
Maharjan S; Kertesz SG; Bhattacharya K; Markland A; McGwin G; Yang Y; Bentley JP; Ramachandran S
J Am Pharm Assoc (2003); 2023; 63(6):1753-1760.e5. PubMed ID: 37633452
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Long-Term Prescription Opioid Use Among Older Adults in the United States: A Study of Medicare Administrative Claims Data.
Ramachandran S; Salkar M; Bentley JP; Eriator I; Yang Y
Pain Physician; 2021 Jan; 24(1):31-40. PubMed ID: 33400426
[TBL] [Abstract][Full Text] [Related]
3. Rates of Physician Coprescribing of Opioids and Benzodiazepines After the Release of the Centers for Disease Control and Prevention Guidelines in 2016.
Jeffery MM; Hooten WM; Jena AB; Ross JS; Shah ND; Karaca-Mandic P
JAMA Netw Open; 2019 Aug; 2(8):e198325. PubMed ID: 31373650
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of psychotropic and opioid prescribing among hospice beneficiaries in the United States, 2014-2016.
Gerlach LB; Kales HC; Kim HM; Zhang L; Strominger J; Covinsky K; Teno J; Bynum JPW; Maust DT
J Am Geriatr Soc; 2021 Jun; 69(6):1479-1489. PubMed ID: 33683703
[TBL] [Abstract][Full Text] [Related]
5. Concurrent use of prescription gabapentinoids with opioids and risk for fall-related injury among older US Medicare beneficiaries with chronic noncancer pain: A population-based cohort study.
Chen C; Winterstein AG; Lo-Ciganic WH; Tighe PJ; Wei YJ
PLoS Med; 2022 Mar; 19(3):e1003921. PubMed ID: 35231025
[TBL] [Abstract][Full Text] [Related]
6. Coprescribing of Benzodiazepines and Opioids in Older Adults: Rates, Correlates, and National Trends.
Rhee TG
J Gerontol A Biol Sci Med Sci; 2019 Nov; 74(12):1910-1915. PubMed ID: 30561526
[TBL] [Abstract][Full Text] [Related]
7. Opioid Coprescribing with Sedatives after Implant-Based Breast Reconstruction.
Santosa KB; Wang CS; Hu HM; Mullen CR; Brummett CM; Englesbe MJ; Bicket MC; Myers PL; Waljee JF
Plast Reconstr Surg; 2022 Dec; 150(6):1224e-1235e. PubMed ID: 36103669
[TBL] [Abstract][Full Text] [Related]
8. Do Formulation and Dose of Long-Term Opioid Therapy Contribute to Risk of Adverse Events among Older Adults?
Salkar M; Ramachandran S; Bentley JP; Eriator I; McGwin G; Twyner CC; Yang Y
J Gen Intern Med; 2022 Feb; 37(2):367-374. PubMed ID: 34258726
[TBL] [Abstract][Full Text] [Related]
9. Guideline-recommended vs high-dose long-term opioid therapy for chronic noncancer pain is associated with better health outcomes: data from a representative sample of the German population.
Häuser W; Schubert T; Scherbaum N; Tölle T
Pain; 2018 Jan; 159(1):85-91. PubMed ID: 28953194
[TBL] [Abstract][Full Text] [Related]
10. Long-term opioid therapy for chronic non-cancer pain in Germany.
Marschall U; L'hoest H; Radbruch L; Häuser W
Eur J Pain; 2016 May; 20(5):767-76. PubMed ID: 26492066
[TBL] [Abstract][Full Text] [Related]
11. Relationship between facility number of clinicians and prescribing intensity of psychotropic medications, opioids, and antibiotics in ambulatory practice.
Kim HM; Strominger J; Zivin K; Van T; Maust DT
BMC Health Serv Res; 2024 Feb; 24(1):217. PubMed ID: 38365679
[TBL] [Abstract][Full Text] [Related]
12. Quality of opioid prescribing in older adults with or without Alzheimer disease and related dementia.
Wei YJ; Schmidt S; Chen C; Fillingim RB; Reid MC; DeKosky S; Solberg L; Pahor M; Brumback B; Winterstein AG
Alzheimers Res Ther; 2021 Apr; 13(1):78. PubMed ID: 33883028
[TBL] [Abstract][Full Text] [Related]
13. Continuity of opioid prescribing among older adults on long-term opioids.
Ramachandran S; Salkar M; Bhattacharya K; Bentley JP; Maharjan S; Eriator I; McGwin G; Mauney MJ; Yang Y
Am J Manag Care; 2023 Feb; 29(2):88-94. PubMed ID: 36811983
[TBL] [Abstract][Full Text] [Related]
14. Opioid dose risk, clinician and patient characteristics, and adherence to opioid prescribing recommendations in chronic non-cancer pain.
Coleman C; Lennon RP; Robinson JM; Tuan WJ; Sehgal N; Zgierska AE
J Opioid Manag; 2023; 19(5):413-422. PubMed ID: 37968975
[TBL] [Abstract][Full Text] [Related]
15. New psychotropic medication use among Medicare beneficiaries with dementia after hospital discharge.
Growdon ME; Gan S; Yaffe K; Lee AK; Anderson TS; Muench U; Boscardin WJ; Steinman MA
J Am Geriatr Soc; 2023 Apr; 71(4):1134-1144. PubMed ID: 36514208
[TBL] [Abstract][Full Text] [Related]
16. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.
Rasu RS; Vouthy K; Crowl AN; Stegeman AE; Fikru B; Bawa WA; Knell ME
J Manag Care Spec Pharm; 2014 Sep; 20(9):921-8. PubMed ID: 25166291
[TBL] [Abstract][Full Text] [Related]
17. Trends in opioid and non-opioid treatment for chronic non-cancer pain and cancer pain among privately insured adults in the United States, 2012-2019.
Bandara S; Bicket MC; McGinty EE
PLoS One; 2022; 17(8):e0272142. PubMed ID: 35947577
[TBL] [Abstract][Full Text] [Related]
18. High opioid doses, naloxone, and central nervous system active medications received by Medicare-enrolled adults.
Silva Almodóvar A; Nahata MC
J Am Geriatr Soc; 2023 Jan; 71(1):98-108. PubMed ID: 36289563
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns.
Raman SR; Bush C; Karmali RN; Greenblatt LH; Roberts AW; Skinner AC
J Manag Care Spec Pharm; 2019 Sep; 25(9):966-972. PubMed ID: 31456497
[TBL] [Abstract][Full Text] [Related]
20. Coprescribing of opioids and high-risk medications in the USA: a cross-sectional study with data from national ambulatory and emergency department settings.
Suvada K; Zimmer A; Soodalter J; Malik JS; Kavalieratos D; Ali MK
BMJ Open; 2022 Jun; 12(6):e057588. PubMed ID: 35710252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
